The resistant cancer type shows higher than normal levels of proteins involved in the replication pathways, including hTS, and cross-resistance with anti-hTS drugs [14,15,16] The above-mentioned anti-hTS drugs become ineffective. The gene discussed is APCDD1; the disease is cancer.